Showing results (11-20 of 291) with videos related to
Sort By:
Pageof 30
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 16, 2014
Why is it so difficult to develop a hepatitis C virus preventive vaccine?C Zingaretti, R De Francesco, S AbrignaniJournal of Hepatology|January 6, 2000
Perspectives for a vaccine against hepatitis C virusS Abrignani, M Houghton, H H HsuScience (New York, N.Y.)|October 30, 1998
Binding of hepatitis C virus to CD81P Pileri, Y Uematsu, S Campagnoli, et al.Virology|September 7, 2001
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant FabsR Burioni, F Bugli, N Mancini, et al.Cellular Immunology|February 1, 1988
Role of macrophages in bypassing the inhibitory activity of Newcastle disease virus on the T-suppressor-cell circuit which regulates contact sensitivity to picryl chlorideF Dieli, S Abrignani, D Lio, et al.Hepatology (Baltimore, Md.)|September 10, 1998
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragmentsR Burioni, P Plaisant, A Manzin, et al.Hepatology (Baltimore, Md.)|October 2, 1998
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis CK Ishii, D Rosa, Y Watanabe, et al.AIDS Patient Care and Stds|October 8, 2004
Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulinM Piazza, L Sagliocca, G Tosone, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Prophylaxis of hepatitis C with intramuscular immunoglobulin: clinical and economic appraisalM Piazza, L Sagliocca, G Tosone, et al.Journal of Virology|April 25, 2000
Structure-function analysis of hepatitis C virus envelope-CD81 bindingR Petracca, F Falugi, G Galli, et al.Pageof 30